Astrana HealthASTH +2.37%87 ROC (Joel Greenblatt) % is 152.46% as of Mar. 2026, which is 23% above its 10-year median of 124.41. GuruFocus rates ASTH with a GF Score™ of 87/100 and a GF Value™ of $82.34 (Significantly Undervalued). The stock has 8 warning signs investors should review. Among 673 Healthcare Providers & Services companies, Astrana Health ranks better than 91.23% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Astrana Health's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 152.46%.
The historical rank and industry rank for Astrana Health's ROC (Joel Greenblatt) % or its related term are showing as below:
ASTH'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -841.75 Med: 124.41 Max: 1194.71
Current: 144.97
During the past 13 years, Astrana Health's highest ROC (Joel Greenblatt) % was 1194.71%. The lowest was -841.75%. And the median was 124.41%.
ASTH's ROC (Joel Greenblatt) % is ranked better than 91.23% of 673
companies
in the Healthcare Providers & Services industry
Industry Median: 12.46
vs ASTH: 144.97
Astrana Health's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 29.50% per year.
Astrana Health (NAS:ASTH) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
Astrana Health ROC (Joel Greenblatt) % Related Terms
Astrana Health ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Astrana Health's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASTH vs MD, SGRY, ADUS: ROC (Joel Greenblatt) % Comparison
For the Medical Care Facilities subindustry, Astrana Health's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Astrana Health ROC (Joel Greenblatt) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Astrana Health's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Astrana Health's ROC (Joel Greenblatt) % falls into.
Astrana Health ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 152.46% mean?
Astrana Health (ASTH) has a ROC (Joel Greenblatt) % of 152.46% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Astrana Health and its competitors. This is 23% above median its historical median of 124.41. According to the industry distribution chart, Astrana Health ranks #59 out of 673 companies in the Healthcare Providers & Services industry, placing it in the top 8.8%.
Is Astrana Health's ROC (Joel Greenblatt) % too high?
Astrana Health's current ROC (Joel Greenblatt) % of 152.46% is 23% above median its 10-year median of 124.41. The Healthcare Providers & Services industry median ROC (Joel Greenblatt) % is 12.46. Astrana Health's value of 152.46% is 1123.6% above this industry median. Based on the distribution chart, Astrana Health ranks #59 out of 673 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Astrana Health has a GF Score™ of 87/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Astrana Health's ROC (Joel Greenblatt) % compare to MD and SGRY?
According to the Healthcare Providers & Services industry distribution chart, Astrana Health ranks #59 out of 673 companies for ROC (Joel Greenblatt) %. This places Astrana Health in the top 9% of its industry — outperforming the majority of peers. The industry median ROC (Joel Greenblatt) % is 12.46. Astrana Health's value of 152.46% is 1123.6% above this benchmark. While the company's 10-year median is 124.41 vs. the industry median of 12.46, Astrana Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median ROC (Joel Greenblatt) % among Healthcare Providers & Services companies is 12.46, based on 673 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Astrana Health's current ROC (Joel Greenblatt) % of 152.46% is 1123.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Astrana Health and its competitors. For the Healthcare Providers & Services industry, the median ROC (Joel Greenblatt) % is 12.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Astrana Health's current ROC (Joel Greenblatt) % is 152.46%, which is 23% above median its own 10-year median of 124.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astrana Health stock overvalued right now?
Based on GuruFocus' analysis, Astrana Health (ASTH) is currently considered Significantly Undervalued. The stock's GF Value™ is $82.34, compared to a current price of $44.43 — trading 46% below its estimated fair value. The current ROC (Joel Greenblatt) % is 152.46%, which is 23% above median its 10-year median of 124.41 and 1123.6% above the Healthcare Providers & Services industry median of 12.46. Astrana Health's overall GF Score™ is 87/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Astrana Health (ASTH), the current ROC (Joel Greenblatt) % is 152.46% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Astrana Health (ASTH) Overvalued in 2026?
Based on GuruFocus' analysis, Astrana Health stock appears to be undervalued.
The current stock price of $44.43 is trading 46% below its estimated GF Value™ of $82.34.
GuruFocus considers Astrana Health to be Significantly Undervalued.
Key valuation signals for ASTH:
ROC (Joel Greenblatt) %: 152.46% (23% above median its 10-year median of 124.41)
GF Value™: $82.34 vs. price of $44.43 (46% below fair value)
Industry Position: 1123.6% above the Healthcare Providers & Services median (#59 of 673)
No single metric tells the full story. See the ASTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
87GF Score
Get the complete analysis for ASTH
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASTH has been successfully added to your 
